Trump Administration Adds 160 Drugs to TrumpRx Direct-to-Consumer Platform
President Trump announced Friday that TrumpRx.gov will add 160 prescription medications to its direct-to-consumer platform, bringing the total to over 800 drugs available at discounted prices. This marks the second expansion of the initiative in two months. The platform sells drugs directly to consumers, bypassing traditional pharmacy channels. The announcement did not specify which drugs were added or provide details about pricing structures or manufacturer participation.
Federal direct-to-consumer drug sales could affect Medicaid managed care pharmacy benefit management, prescription volume through contracted pharmacies, and MCO pharmacy rebate arrangements if beneficiaries shift purchasing patterns.
Pharmacy · Managed Care
You might also like